Immediate Impact
50 standout
Citing Papers
MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future
2024 Standout
Innovations in Biosensor Technologies for Healthcare Diagnostics and Therapeutic Drug Monitoring: Applications, Recent Progress, and Future Research Challenges
2024 Standout
Works of Anna Urbaniak being referenced
Prolactin-induced protein (PIP)-characterization and role in breast cancer progression.
2018
Prognostic relevance of proliferating cell nuclear antigen and p53 expression in non-small cell lung cancer
2002
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Anna Urbaniak | 122 | 47 | 69 | 19 | 331 | |
| Kimihiko Takada | 153 | 35 | 58 | 19 | 327 | |
| Tianhe Li | 131 | 60 | 48 | 22 | 321 | |
| Yuanhua Qin | 155 | 40 | 82 | 25 | 351 | |
| Shabbir A. Ansari | 175 | 44 | 59 | 13 | 338 | |
| Kateřina Pospěchová | 103 | 89 | 50 | 14 | 343 | |
| Nouf S. Al‐Numair | 129 | 26 | 65 | 28 | 348 | |
| Bin Wang | 179 | 38 | 42 | 22 | 333 | |
| Jerzy Barankiewicz | 173 | 52 | 50 | 25 | 366 | |
| Xiaoqin Zheng | 138 | 40 | 71 | 24 | 357 | |
| Guohua Ding | 100 | 29 | 92 | 17 | 333 |
All Works
Login with ORCID to disown or claim papers
Loading papers...